Ventricular Tachycardia Market, By Drug Type (Antiarrhythmic Drugs, Anticoagulants, Vasodilators, and ACE Inhibitors), By Drug Class (Class I (Sodium Channel Blockers), Class II (Beta-Blockers), Class III (Potassium Channel Blockers), Class IV (Calcium Channel Blockers), and Other Classes), By Disease Type (Non-Ischemic Ventricular Tachycardia and Ischemic Ventricular Tachycardia), By Route of Administration (Oral, Intravenous, and Subcutaneous), By Therapy Line (First-Line Therapy, Second-Line Therapy, and Rescue/Refractory Therapy), By Patient Age Group (Pediatric, Adult, and Geriatric), By Type (Brand and Generic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals, Cardiac Care Centers, Emergency Care Units, and Ambulatory Care Settings), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)